Sarepta Therapeutics CEO Chris Garabedian resigns
April 01, 2015 at 08:54 AM EDT
Biotech’s Chief Marketing Officer Edward Kaye will take over as interim CEO.
Sarepta Therapeutics CEO Chris Garabedian resigns
By:
MarketWatch
April 01, 2015 at 08:54 AM EDT
Biotech’s Chief Marketing Officer Edward Kaye will take over as interim CEO.
Related Stocks:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|